• Home
  • About
  • Press
  • Services
  • Legal
  • Payment
  • Contact
  • Facebook
  • Twitter
The Wall Street Analyzer

  • Featured Interviews
  • CEO Interviews
  • News Feed
  • Spotlight
  • Sectors
    • Biotech
    • Cannabis
    • Consumer
    • Energy
    • Healthcare
    • Market News
    • Technology
Latest News
  • [ February 12, 2026 ] Rain Enhancement Technologies Reports More Than 20% Snowpack Enhancement in Utah During January Operations News Feed
  • [ February 10, 2026 ] SafeSpace Global Corp. (OTCID: SSGC) Announces Investor Day to be held in Nashville, Tennessee on February 27, 2026 News Feed
  • [ February 9, 2026 ] Earth Science Tech, Inc. (ETST), to Report Financial Results for Fiscal Third Quarter on February 17, 2026 News Feed
  • [ February 6, 2026 ] Rain Enhancement Technologies Expands Research into Air Quality and Smog Mitigation Consumer
  • [ January 30, 2026 ] Magna Terra Expands Land Position in Northern New Brunswick; Acquires the Oxford Project News Feed
  • [ January 27, 2026 ] SafeSpace to Showcase Growth Strategy at the DealFlow Discovery Conference News Feed
  • [ January 26, 2026 ] Tom Lee: Energy and basic materials are the top sector picks this year Market News
HomeAuthorsThe Wall Street Analyzer

Articles by The Wall Street Analyzer

About The Wall Street Analyzer
The Wall Street Analyzer's staff of writers, analysts, publishers, producers, market researchers, and PR professionals aim to provide investors with the tools they need to make informed decisions on buying stock. Our staff is a mix of financial professionals and media savvy individuals whose experiences bring the best talent from both ends of the spectrum.
No Picture
News Feed

Immune Pharmaceuticals Secures Funding of up to $21.5 Million from Institutional Investors

July 30, 2015 The Wall Street Analyzer Comments Off on Immune Pharmaceuticals Secures Funding of up to $21.5 Million from Institutional Investors

Up to $9.5 Million in Debt Financing and $12 Million in Equity Financing.

Company to Advance its Immuno-Dermatology and Inflammatory Bowel Disease Product Candidates
Lead Compound Bertilimumab, First-in-Class Autoimmune Therapy, a Priority
[…]

No Picture
News Feed

Educational Development Corporation Announces Results for First Quarter of Fiscal Year 2016

July 20, 2015 The Wall Street Analyzer Comments Off on Educational Development Corporation Announces Results for First Quarter of Fiscal Year 2016

NASDAQ:EDUC […]

No Picture
News Feed

Pacific Energy Development Announces Commencement of Drilling This Week on Seven New Wattenberg Wells

July 20, 2015 The Wall Street Analyzer Comments Off on Pacific Energy Development Announces Commencement of Drilling This Week on Seven New Wattenberg Wells

Will Also Participate in Additional Wattenberg Well […]

No Picture
News Feed

WSA Spotlights Three Canadian Companies in June That Are Making Big Moves

July 15, 2015 The Wall Street Analyzer Comments Off on WSA Spotlights Three Canadian Companies in June That Are Making Big Moves

Wall Street Analyzer’s CEO Interview Series […]

CEO Interviews

AirBoss of America Corp (TSX:BOS) (OTC:ABSSF) Management Interview

July 14, 2015 The Wall Street Analyzer Comments Off on AirBoss of America Corp (TSX:BOS) (OTC:ABSSF) Management Interview

Management Interview […]

No Picture
CEO Interviews

Chanticleer Holdings, Inc (NASDAQ:HOTR) CEO Interview

July 7, 2015 The Wall Street Analyzer Comments Off on Chanticleer Holdings, Inc (NASDAQ:HOTR) CEO Interview

Chanticleer Holdings, Inc (NASDAQ:HOTR) President and CEO: Michael Pruitt   THIS INTERVIEW HAS EXPIRED  

No Picture
News Feed

OCI Partners LP Announces Closing of New Incremental Term Loan

July 6, 2015 The Wall Street Analyzer Comments Off on OCI Partners LP Announces Closing of New Incremental Term Loan

(NYSE:OCIP) […]

No Picture
CEO Interviews

NioCorp Developments Ltd (TSXV:NB) (OTCQX:NIOBF) CEO: Mark Smith

June 23, 2015 The Wall Street Analyzer Comments Off on NioCorp Developments Ltd (TSXV:NB) (OTCQX:NIOBF) CEO: Mark Smith

Interview with CEO Mark Smith […]

No Picture
CEO Interviews

biOasis TECHNOLOGIES INC. (TSX VENTURE:BTI) (OTCQX:BIOAF) CEO Interview

June 22, 2015 The Wall Street Analyzer Comments Off on biOasis TECHNOLOGIES INC. (TSX VENTURE:BTI) (OTCQX:BIOAF) CEO Interview

Interview with CEO Rob Hutchison […]

CEO Interviews

PEDEVCO Corp. (NYSE MKT: PED) CEO Interview

June 18, 2015 The Wall Street Analyzer Comments Off on PEDEVCO Corp. (NYSE MKT: PED) CEO Interview

Interview with Frank Ingriselli, CEO […]

Posts navigation

« 1 … 143 144 145 … 165 »

News Wire

  • Rain Enhancement Technologies Reports More Than 20% Snowpack Enhancement in Utah During January Operations
    February 12, 2026 0
  • SafeSpace Global Corp. (OTCID: SSGC) Announces Investor Day to be held in Nashville, Tennessee on February 27, 2026
    February 10, 2026 0
  • Earth Science Tech, Inc. (ETST), to Report Financial Results for Fiscal Third Quarter on February 17, 2026
    February 9, 2026 0
  • Rain Enhancement Technologies Expands Research into Air Quality and Smog Mitigation
    February 6, 2026 0
  • Magna Terra Expands Land Position in Northern New Brunswick; Acquires the Oxford Project
    January 30, 2026 0
  • SafeSpace to Showcase Growth Strategy at the DealFlow Discovery Conference
    January 27, 2026 0

Featured

CEO Interviews

Magna Terra Resources (TSXV: MTT) (OTC: BRIOF)

November 17, 2025 0

Interview with Lewis Lawrick, CEO and President […]

Featured Interviews

TERRA CLEAN ENERGY CORP. (CSE: TCEC, OTCQB: TCEFF, FSE: 9O0)

September 22, 2025 0

Interview with Greg Cameron, CEO […]

CEO Interviews

Rain Enhancement Technologies Holdco, Inc. (NASDAQ:RAIN)

September 5, 2025 0

Interview with Randall Seidl, CEO […]

CEO Interviews

SafeSpace Global Corp (OTC PINK: SSGC)

July 14, 2025 Comments Off on SafeSpace Global Corp (OTC PINK: SSGC)

Interview with Scott Boruff, CEO […]




About Us

The Wall Street Analyzer's staff of writers, analysts, publishers, producers, market researchers, and PR professionals aim to provide investors with the tools they need to make informed decisions on buying stock. Our staff is a mix of financial professionals and media savvy individuals whose experiences bring the best talent from both ends of the spectrum.
Quick links
  • Home
  • About
  • Press
  • Services
  • Legal
  • Payment
  • Contact
Stay connected
  • Facebook
  • Twitter
Recent Case Study
Biotech

Prodex, Inc (NASDAQ: PDEX)

June 20, 2023 Comments Off on Prodex, Inc (NASDAQ: PDEX)

Interview with Rick Van Kirk, CEO […]

Testimonials
Testimonials

Client Testimonials:

March 6, 2023 Comments Off on Client Testimonials:

“Our clients have been very pleased with the Wall Street Analyzer interviews. These have been in-depth pieces with thoughtful and educated questions which have afforded our clients a platform to fully articulate their company story […]

Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com